Healthcare Contract Research Organization Market Size, Share, and Trends 2024 to 2034

The global healthcare contract research organization market size was accounted for USD 53.91 billion in 2024, grew to USD 57.64 billion in 2025 and is predicted to surpass around USD 105.26 billion by 2034, representing a healthy CAGR of 6.92% between 2025 and 2034.

  • Last Updated : December 2024
  • Report Code : 1538
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Healthcare Contract Research Organization Market 

5.1. COVID-19 Landscape: Healthcare Contract Research Organization Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Healthcare Contract Research Organization Market, By Type

8.1. Healthcare Contract Research Organization Market, by Type, 2025-2034

8.1.1. Pre-Clinical

8.1.1.1. Market Revenue and Forecast (2022-2034)

8.1.2. Clinical

8.1.2.1. Market Revenue and Forecast (2022-2034)

8.1.3. Drug Discovery

8.1.3.1. Market Revenue and Forecast (2022-2034)

Chapter 9. Global Healthcare Contract Research Organization Market, By Service

9.1. Healthcare Contract Research Organization Market, by Service, 2025-2034

9.1.1. Data Management

9.1.1.1. Market Revenue and Forecast (2022-2034)

9.1.2. Clinical Supply Management/Project Management

9.1.2.1. Market Revenue and Forecast (2022-2034)

9.1.3. Medical Writing

9.1.3.1. Market Revenue and Forecast (2022-2034)

9.1.4. Clinical Monitoring

9.1.4.1. Market Revenue and Forecast (2022-2034)

9.1.5. Patient & Site Recruitment

9.1.5.1. Market Revenue and Forecast (2022-2034)

9.1.6. Bio-Statistics

9.1.6.1. Market Revenue and Forecast (2022-2034)

9.1.7. Regulatory & Medical Affairs

9.1.7.1. Market Revenue and Forecast (2022-2034)

9.1.8. Investigator Payments

9.1.8.1. Market Revenue and Forecast (2022-2034)

9.1.9. Technology

9.1.9.1. Market Revenue and Forecast (2022-2034)

9.1.10. Laboratory

9.1.10.1. Market Revenue and Forecast (2022-2034)

9.1.11. Quality Management

9.1.11.1. Market Revenue and Forecast (2022-2034)

9.1.12. Others

9.1.12.1. Market Revenue and Forecast (2022-2034)

Chapter 10. Global Healthcare Contract Research Organization Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Type (2022-2034)

10.1.2. Market Revenue and Forecast, by Service (2022-2034)

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Type (2022-2034)

10.1.3.2. Market Revenue and Forecast, by Service (2022-2034)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Type (2022-2034)

10.1.4.2. Market Revenue and Forecast, by Service (2022-2034)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Type (2022-2034)

10.2.2. Market Revenue and Forecast, by Service (2022-2034)

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Type (2022-2034)

10.2.3.2. Market Revenue and Forecast, by Service (2022-2034)

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Type (2022-2034)

10.2.4.2. Market Revenue and Forecast, by Service (2022-2034)

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Type (2022-2034)

10.2.5.2. Market Revenue and Forecast, by Service (2022-2034)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Type (2022-2034)

10.2.6.2. Market Revenue and Forecast, by Service (2022-2034)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Type (2022-2034)

10.3.2. Market Revenue and Forecast, by Service (2022-2034)

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Type (2022-2034)

10.3.3.2. Market Revenue and Forecast, by Service (2022-2034)

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Type (2022-2034)

10.3.4.2. Market Revenue and Forecast, by Service (2022-2034)

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Type (2022-2034)

10.3.5.2. Market Revenue and Forecast, by Service (2022-2034)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Type (2022-2034)

10.3.6.2. Market Revenue and Forecast, by Service (2022-2034)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Type (2022-2034)

10.4.2. Market Revenue and Forecast, by Service (2022-2034)

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Type (2022-2034)

10.4.3.2. Market Revenue and Forecast, by Service (2022-2034)

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Type (2022-2034)

10.4.4.2. Market Revenue and Forecast, by Service (2022-2034)

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Type (2022-2034)

10.4.5.2. Market Revenue and Forecast, by Service (2022-2034)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Type (2022-2034)

10.4.6.2. Market Revenue and Forecast, by Service (2022-2034)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Type (2022-2034)

10.5.2. Market Revenue and Forecast, by Service (2022-2034)

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Type (2022-2034)

10.5.3.2. Market Revenue and Forecast, by Service (2022-2034)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Type (2022-2034)

10.5.4.2. Market Revenue and Forecast, by Service (2022-2034)

Chapter 11. Company Profiles

11.1. QVIA

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. LabCorp

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Charles River Laboratories

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. WuXiAppTec

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Syneos Health

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Parexel International

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. PPD

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. ICON Plc

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Medpace Holdings

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. SGS

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

According to Precedence Research, the global healthcare contract research organization market was valued at USD 53.91 billion in 2024 and is anticipated to hit over USD 105.26 billion by 2034.

The global healthcare contract research organization market is expected to drive growth at a CAGR of 6.92% from 2025 to 2034.

The rising prevalence of various chronic diseases and rapidly growing geriatric population is boosting the demand for the various new and innovative life-saving drugs across the globe.

The major players operating in the healthcare contract research organization market are QVIA, LabCorp, Charles River Laboratories, WuXiAppTec, Syneos Health, Parexel International, PPD, ICON Plc, Medpace Holdings, SGS, PSI CRO AG, Axcent Advanced Analytics, BIO Agile Therapeutics, Firma Clinical Research, and Acculab Life Sciences.

Asia Pacific dominated the global healthcare contract research organization market in 2024 and will lead the market in next decade.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client